Reading G? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track G free→Reading G? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track G free→
NYSEIndustrialsInformation Technology ServicesSnapshot 2026-06-12
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
Recent financial performance is strong, but risk is elevated and the sector backdrop is a headwind. Earnings quality is neutral, and compared with sector peers, G trades above typical levels. Peer multiples imply a price about 62% above where it trades (it looks cheap on this basis); the read is cheap, quality intact. The outlook hinges on guidance changes and sector trends, particularly the performance of key bellwethers in the Industrials sector. This read is provisional.
Daily closes. Earnings/event dots are placed inline.
A consensus fair price across 7 valuation methods, at three horizons. Current price $32.06. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $32 G trades at 8× p/e, below its 23× p/e peer median. Our $85 fair value sits above the price; medium confidence. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
The price implies about 62% below a flat-multiple fair value, below our forecast of about 5%. This describes what's priced in, not a forecast of the move.
Only weak execution quality — not the full expensive x weak x turbulent stack.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 3 of the last 3 quarter-over-quarter moves. Historically, Industrials names rated strong grew net income 69% of the time over the next year (vs 58% for the rest of the cohort, n=3696).
Over the trailing year it converted 1.31x of net income into operating cash flow. Historically, Industrials names rated neutral grew net income 57% of the time over the next year (vs 60% for the rest of the cohort, n=4440).
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to the US dollar, real (inflation-adjusted) rates, long-term interest rates, Fed net liquidity.
Not enough signal yet.
The next print and the backdrop around it (sector regime and the AI cycle). Context for the path, not a forecast of returns.
EPS estimate $0.97 → $0.97 (-0.9% / 30d). 2 raised, 7 cut, 11 covering analysts.
0 upgrades, 0 downgrades / 30d. 42% of analysts rate Buy.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
What a normal day, a bad day, and the worst of the last year would mean for a $10,000 position.
On a typical day, $10k can swing ±$114.
How much price usually moves either way.
On a bad day, this stock has moved -$347.
A rough but not unusual down day (about the 95th percentile).
In the worst 12 months, $10k could have lost $4,004.
Deepest peak-to-trough drop in the last year.
Past results, not a forecast. Not investment advice.
The most important moves since the prior daily snapshot.
No material changes since the prior snapshot.
as of 2026-06-12
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: This growth target is key for Genpact's performance in 2026. Meeting it shows strong demand.
Confirms:Q2 revenue growth reported at 7% or higher year over year.
Disproves:Q2 revenue growth reported below 7% year over year.
Recent news graded against this company's own objectives — whether it reinforces or challenges the thesis, and how confirmed it is.
No graded news catalysts for G yet.
Conditional scenarios: if X happens, the view would shift in this direction. These are not predictions.
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
and shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. The Company is making reference to non-GAAP financial informati…
Whether the overall read has been drifting up or down lately, and how it's changed since last week.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Long-thesis check; widest uncertainty.
Looks cheaper than most peers in the same business.
Cheaper than its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
A side-by-side read on sector standing, valuation, and risk versus Industrials (broad).
| Stock | Sector standing | Valuation | Risk |
|---|---|---|---|
G Genpact | Above typical Show detailsSector percentile: 99 of 100 | inexpensive | elevated |
MTZ MasTec | Typical Show detailsSector percentile: 47 of 100 | expensive | moderate |
CW Curtiss-Wright | Typical Show detailsSector percentile: 67 of 100 | expensive | moderate |
CRS Carpenter Technology | Typical Show detailsSector percentile: 55 of 100 | expensive | moderate |
ATI ATI Inc. | Above typical Show detailsSector percentile: 85 of 100 | expensive | elevated |
Not investment advice. As of 2026-06-12.
via XLI
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive. Historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only: describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-06-12.
Met or beat guidance 100% of the last 1 guided quarters · 8.4% avg surprise
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Genpact aims to achieve a net revenue growth of at least 7% for the fiscal year 2026.
Genpact aims to maintain an adjusted income from operations margin of 17.7% for 2026.
Genpact aims to achieve an adjusted diluted EPS of $4.04 for the fiscal year 2026.
Why it matters: Changes in unemployment claims can signal economic health. This affects demand for Genpact's services.
Confirms one read:Claims drop below 200,000, indicating a stronger job market.
Confirms the other:Claims go over 300,000. This points to possible economic weakness.
Why it matters: This EPS target is a key indicator of overall financial health and growth.
Confirms:Adjusted diluted EPS is $4.04 or higher.
Disproves:Adjusted diluted EPS is below $4.04.
Why it matters: Earnings results will show if Genpact's financial health is improving or declining. Investors will react strongly to the numbers.
Confirms one read:Earnings per share (EPS) exceeds $0.50, indicating strong performance.
Confirms the other:EPS falls below $0.30, signaling potential issues in growth.
Why it matters: If the industrial sector's revenue growth picks up, it could benefit Genpact's business. This would be a positive sign for the company.
Confirms:Revenue growth in the industrial sector exceeds 10% year over year.
Disproves:Revenue growth is under 5% year over year. This shows it is slowing down.